Article Details

Equities Analysts Issue Forecasts for Fate Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:FATE)

Retrieved on: 2021-06-08 09:56:01

Tags for this article:

Click the tags to see associated articles and topics

Equities Analysts Issue Forecasts for Fate Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:FATE). View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-fate-analyst-earnings-estimates-2021-06/

Excerpt

BlackRock Inc. now owns 7,163,487 shares of the biopharmaceutical company's stock valued at $590,628,000 after buying an additional 491,946 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up